San Francisco, CA – April 6, 2014.  Station X and Molecular Response have teamed up to rapidly data mine large cohorts of cancer genomics data in search of novel targets and predictive markers. This data derives from both drug-naïve and -treated patient-derived cancer samples. To serve as the drug-naïve reference, this study looks to the thousands of patient-derived tumor specimens, covering 25+ tissue types, genomically characterized by The Cancer Genome Atlas and freely available in GenePool Reference™.  For both drug-naïve and drug-treated primary data, this study leverages Molecular Response’s proprietary bank of viable cryopreserved tumor cells. The bank contains more than 144,000 tumor specimens, covering 25 tissue types and 76 clinical diagnoses. Each of the specimens has been profiled against a panel of drugs ex vivo, and levels of resistance recorded. Nearly 400 tumor specimens from Molecular Response’s proprietary bank have been genomically characterized so far. 

Station X and Molecular Response will be presenting poster #4279 at AACR 2014 titled "Rapid biomarker discovery using large-scale, patient-derived cancer genomic cohorts". Please stop by on Tuesday (April 8th, 2014) 1:00-5:00pm at Hall A-E, Poster Section 19 to meet with us and check out the poster!

If you'd like a copy of the poster, it is now available as a downloadable PDF, or please contact us at info@stationxinc.com.